<!DOCTYPE html>
<html xmlns:og="http://opengraphprotocol.org/schema/">
    <head>
        <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no">
        <meta http-equiv="content-type" content="text/html; charset=utf-8" />
        <title>	2023-06029 - PhD Position F/M [Campagne DOC MI-NF-LYS-2023] Evaluation of Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening in combination with anti-TIM3 therapeutic antibodies in preclinical mathematical model of Glioblastomas
</title>
        <link rel="icon" type="image/x-icon" href="../../../../favicon-16x16.png"/>
        <script type="text/javascript" src="../../../../js/jquery/jquery-1.9.1.js"></script>
        <script type="text/javascript" src="../../../../css/bootstrap-3.3.4/js/bootstrap.js"></script>
        	<meta property="og:description" content="Offre d'emploi Inria" />
	<meta property="og:title" content="PhD Position F/M [Campagne DOC MI-NF-LYS-2023] Evaluation of Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening in combination with anti-TIM3 therapeutic antibodies in preclinical mathematical model of Glioblastomas" />
	<meta property="og:url" content="http://jobs.inria.fr/public/classic/fr/offres/2023-06029" />
	<meta property="og:locale" content="fr_FR" />
	<meta property="og:site_name" content="Inria"/>
	<meta property="og:type" content="article" />
        	            <link rel="stylesheet" href="../../../../css/bootstrap-3.3.4/css/bootstrap.min.css"/>
            <link rel="stylesheet" href="../../../../library/bootstrap-select-1.12.2/dist/css/bootstrap-select.min.css"/>
            <link rel="stylesheet" href="../../../../css/bootstrap/bootstrap-datetimepicker.css"/>
            <link rel="stylesheet" href="../../../../library/font-awesome-4.7.0/css/font-awesome.css"/>
            <link rel="stylesheet" href="../../../../css/fonts/fonts.css"/>
            <link rel="stylesheet" href="../../../../css/app/main_public.css" />
            <link rel="stylesheet" href="../../../../css/inria.css"/>
        
	<link property="stylesheet" rel="stylesheet" href="../../../../css/app/detailOffre.css" />
    </head>
<body  style="background-image: url('../../../../images/bg-jobs.png') ">
    
<nav id="toplinklist" class="nav navbar-nav navbar-default navbar-fixed-top" >
    <div class="navbar-inner">
        <div class="container">
            <div class="navbar-header">
                                <a href="../offres.html" class="pull-left inriatoplinklogo">
                    <img alt="Inria" width="30%" src="https://commons.inria.fr/images/logo/inr_logo_sans_sign_rouge.jpg" />
                </a>
                                <button type="button" class="navbar-toggle toplinktoggle" data-toggle="collapse" data-target="#navbar-collapse-menuTop">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse" id="navbar-collapse-menuTop">
                <ul class="nav navbar-nav navbar-right">
                                        <li class="visible-xs text-right toplinktoggle-remove nav-profil-menu" data-toggle="collapse" data-target="#navbar-collapse-menuTop">
                        <i class="inria-gray3 fa fa-remove fa-2x"></i></li>
                    <li class=" text-center picto-lang nav-profil-menu" >
                                                                        <span class="toplang-button">
                            <a class="inria-gray2" href="../../fr/offres/2023-06029.html" title="FranÃ§ais">
                                FR
                            </a> <span class="inria-gray2">|</span>
                            <a class="a-inria" href="2023-06029.html" >EN</a>
                            </span>
                                            </li>

                                                                                                    <li class="dropdown text-center nav-profil-menu">
                        <a href="2023-06029.html#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">
                            <img alt="user" src="../../../../images/user.png">
                                                        <p style="color: black;">
                                Account <span class="caret"></span>
                            </p>
                                                    </a>
                        <ul class="dropdown-menu">
                                                        <li><a href="../../../en/connect.html"> <span class="fa fa-sign-in"></span> Sign in</a></li>
                            <li><a href="../../../en/register.html"><span class="fa fa-plus"></span> Register</a></li>
                                                    </ul>
                    </li>
                                </ul>
            </div><!-- /.navbar-collapse -->
          </div><!-- /.container -->
    </div><!-- /.navbar-inner -->
</nav>


<!-- Bouton Scroll -->
<div class="row">
    <div class="col-md-12">
        <div class="visible-sm visible-xs">
            <a href="2023-06029.html#" title="Haut de page" class="scrollup scrollup-sm link-btn" type="button">
                <i class="fa fa-chevron-up"></i>
            </a>
        </div>
        <div class="visible-md">
            <a href="2023-06029.html#" title="Haut de page" class="scrollup scrollup-md link-btn" type="button">
                <i class="fa fa-chevron-up"></i>
            </a>
        </div>
        <div class="visible-lg">
            <a href="2023-06029.html#" title="Haut de page" class="scrollup scrollup-lg link-btn" type="button">
                <i class="fa fa-chevron-up"></i>
            </a>
        </div>
    </div>
</div>
<!-- Main content -->
<div class="col-md-12 main-content" style="height:auto;">
    <div class="row">
        <div class="col-xs-10 col-xs-offset-1 col-lg-8 col-lg-offset-2 menu-breadcrumb">
            <a href="https://jobs.inria.fr/public/classic/en/offres?locale=en" class="a-inria">
        Home
        </a>
         > 
        <a href="https://jobs.inria.fr/public/classic/en/offres?locale=en" class="a-inria">List of vacancies</a>
         > Detail of a job vacancy        </div>
    </div>
    <div class="row" ><div  class="col-xs-10 col-xs-offset-1 col-md-8 col-lg-6 col-lg-offset-2"></div></div>
<div class="row">
    <div class="col-md-12 col-lg-10 col-lg-offset-1">
        <div class="row">
                    
                <div id="left" class="col-sm-7 col-lg-6 col-lg-offset-1 block-left">
                    <div class="list-group list-group-item" style="padding: 6%; font-size: 16px;">
                                              <div class="row">
                            <span class="h4-inria intitule-detail-offre col-xs-10 col-sm-11"> 
                                <b>2023-06029 - PhD Position F/M [Campagne DOC MI-NF-LYS-2023] Evaluation of Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening in combination with anti-TIM3 therapeutic antibodies in preclinical mathematical model of Glioblastomas</b>
                            </span>
                            <span class=" col-xs-2 col-sm-1">
                            <a class="a-inria" class="pdf-link"  href="https://jobs.inria.fr/public/classic/en/offres/2023-06029/topdf" title="PDF">
                            	<i class="fa fa-file-pdf-o fa-2x pull-right"></i>
                            </a>
                            </span> 
                        </div>
                        <div class="row">
                         <span class=" h4 col-xs-10 col-sm-11"> 
                                                                                                        </span>
                        </div>
                                						
		<div class="grand-item-offre">
		
				<div class="item-offre">	    	
	    	<p class="list-group-item-text"><b>Contract type : </b>
	        	Fixed-term contract
	        </p>	        
	    </div>
	    	    
	    	    
	    	    <div class="item-offre">
	    	<p class="list-group-item-text"><b>Level of qualifications required : </b>
	        	Graduate degree or equivalent
	        </p>
	    </div>
	    	    
	    	    
	    	    
	    		<div class="item-offre">
	    	<p class="list-group-item-text"><b>Fonction : </b>
	        	PhD Position
	        </p>
	    </div>
	    	    
	    	    
	    	    
	        </div>
    
        
        <div class="grand-item-offre">
    	<h4 class="list-group-item-heading">About the research centre or Inria department</h4>
    	<div class="list-group-item-text text-justify">
    		<p>The Inria research centre in Lyon is the 9th Inria research centre, formally created in January 2022.&nbsp; It brings together approximately 300&nbsp;people in 16 research teams and research support services.</p>
<p>Its staff are distributed at this stage on 2 campuses: in Villeurbanne La Doua (Centre / INSA Lyon / UCBL) on the one hand, and Lyon Gerland (ENS de Lyon) on the other.</p>
<p>The Lyon centre is active in the fields of software, distributed and high-performance computing, embedded systems, quantum computing and privacy in the digital world, but also in digital health and computational biology.</p>
    	</div>
    </div>
        
        <div class="grand-item-offre">
    	<h4 class="list-group-item-heading">Context</h4>
    	<div class="list-group-item-text text-justify">
    		<p>This thesis will take place at Inria Lyon, located on the Campus La Doua, in collaboration with:</p>
<ul>
<li><span lang="fr-FR">Annabelle Ballesta (Researcher Inserm, Paris):&nbsp;Sensitivity analysis and parameter estimation:&nbsp;<a href="https://institut-curie.org/personne/annabelle-ballesta">https://institut-curie.org/personne/annabelle-ballesta</a></span></li>
<li><span lang="fr-FR">Ahmed Idbaih (Onco-neurology, H&ocirc;pital Piti&eacute;-Salp&ecirc;tri&egrave;re, Paris)&nbsp;et&nbsp;</span>Mait&eacute; Verreault (biologist, H&ocirc;pital Piti&eacute;-Salp&ecirc;tri&egrave;re, Paris):&nbsp;Glioblastoma experiment in mice, treated with anti-TIM3 antibody plus LIPU-MBO: <a href="https://www.esmo.org/about-esmo/profiles/ahmed-idbaih">https://www.esmo.org/about-esmo/profiles/ahmed-idbaih</a></li>
</ul>
<p>The person recruited will travel regularly to Paris (on average one day per month) to collaborate with our onco-neurologists and biologists partners.</p>
    	</div>
    </div>
        
        <div class="grand-item-offre">
    	<h4 class="list-group-item-heading">Assignment</h4>
    	<div class="list-group-item-text text-justify">
    		<p align="JUSTIFY"><span lang="en-US"><strong>Motivation and biological context</strong></span></p>
<p align="JUSTIFY">Glioblastoma (GBM) is the most frequent primary malignant tumors of the central nervous system. These infiltrating tumors are associated with an extremely poor prognosis. Immunotherapy by direct stimulation of the immune system with immune checkpoint blockade (ICB), as anti-PD1 and anti-PDL1 therapeutic antibodies, are effective treatments for multiple malignancies but most of GBM patients do not respond to this immunotherapeutic approach.</p>
<p>Several reasons are associated with resistance of GBM to ICB: (i) low immunogenicity -i.e. low mutational burden-, (ii) immunosuppressive microenvironment and, (iii) the blood brain barrier (BBB) limiting drug penetration.&nbsp;Indeed, the BBB is a biophysical and biochemical obstacle for ICB to reach their target. Preclinical and clinical studies showed that ultrasound mediated BBB opening (UMBO) using low-intensity pulsed ultrasound (LIPU) is a safe and effective method to enhance delivery of therapeutic agents to the brain in preclinical and clinical settings.&nbsp;In preclinical models of GBM, efficacy of anti-PDL1 therapeutic antibody is enhanced when administered in combination with LIPU. LIPU increase the delivery of anti-PDL1 antibody to the brain and the tumor, and activate microglia cells. This combination doubled the number of long-term survivors compared to anti-PDL1 administration alone. &nbsp;In the same line, more recently T cell immunoglobulin domain and mucin domain protein 3 (TIM3) has been shown to be the most common co-inhibitory immune checkpoints in GBM expressed by both tumor and non-tumor cells. In addition, TIM3 has been shown to promote tumor growth.</p>
<p>Therefore, inhibiting TIM3 using anti-TIM3 therapeutic antibody appears as a promising strategy. However, therapeutic antibodies are large molecules that do not cross the BBB spontaneously. Therefore, in the present study, we will evaluate the therapeutic and biologic effects of anti-TIM3 antibodies with and without LIPU-MBO in preclinical mathematical model of GBM to increase their brain bioavailability and anti-tumor activity.</p>
<p><strong>Experimental materials and methods (Data)</strong></p>
<p>Our partners will conduct experiments to collect data, they will use two syngeneic GBM mouse models: (i) GL261 and (ii) NFPP10. GL261 is murine GBM and NFPP10 is genetically engineered mouse GBM. Both cells are transduced to express the luciferase allowing noninvasive monitoring of tumor growth. Tumor cells will be engrafted in the right caudate nucleus-putamen of immunocompetent C57BL/6 mice using a stereotactic frame. In both GBM mouse models, TIM3 expression will be assessed using RT-qPCR and immunostaining. Multiplex immunostaining will be performed to identify cell populations expressing TIM3. Tumor bearing mice will be treated with anti-TIM3 antibody plus LIPU-MBO. Several control groups will be used: (i) untreated tumor bearing mice, (ii) tumor bearing mice treated with anti-TIM3 alone and (iii) tumor bearing mice treated with LIPUMBO alone. Each group will include 12 mice. The preclinical trial will be conduct with both GBM models (i.e. GL261 and NFPP10).</p>
<p align="JUSTIFY"><span style="color: #000000;"><span lang="en-US">The endpoints will be: (i) toxicity using limit-points, (ii) anti-tumor efficacy in terms of tumor growth, (iii) anti-tumor efficacy in terms of mice survival, (iv) immune microenvironment modulations and, (vi) brain penetration of anti-TIM3. </span></span></p>
<p align="JUSTIFY"><span style="color: #000000;"><span lang="en-US">The immune microenvironment will be assessed using multiplex immunostaining and FACS sorting. Brain concentration of anti-TIM3 will be assessed using mass spectroscopy.</span></span></p>
<p align="JUSTIFY"><span lang="en-US"><strong>Mathematical modeling</strong></span></p>
<p align="JUSTIFY"><span lang="en-US">We will develop mathematical models for both GBM mouse models,&nbsp;</span><span style="color: #000000;"><span lang="en-US">(i) GL261 and (ii) NFPP10, with and without BHE opening</span></span><span lang="en-US">, based on ordinary differential equations (ODE), delay differential equations (DDE) and structured partial differential equations (PDE). The dynamics of GBM and TIM3 will be studied mathematically in the same scenarios as the experiments: (i) untreated tumor-bearing mice, (ii) tumor-bearing mice treated with anti-TIM3 alone, and (iii) tumor-bearing mice treated with LIP-UMBO alone. </span><span style="color: #000000;"><span lang="en-US">Once the data are available, we will proceed to estimate the model parameters. Analysis of the stability of equilibria and their bifurcation as a function of model parameters (in the autonomous case). Variation of the frequency and duration of opening of the UMBO and its impact on the efficiency of the treatment. Numerical simulation of solutions in different scenarios.</span></span></p>
<p align="JUSTIFY"><span lang="en-US"><strong>Expected results</strong></span></p>
<p align="JUSTIFY"><span lang="en-US">We hypothesize that LIPU-MBO administration will enhance the efficacy of anti-TIM-3 antibodies against in vivo preclinical models of GBM and will be the rational for combining anti-TIM3 with other therapeutic strategies and the rational for a clinical trial in GBM patients.&nbsp;Based on the mathematical model, we will study the best therapeutic strategy combining the use of LIPU-MBO and the administration of anti-TIM-3 antibodies.</span></p>
    	</div>
    </div>
        
        <div class="grand-item-offre">
    	<h4 class="list-group-item-heading">Main activities</h4>
    	<div class="list-group-item-text text-justify">
    		<p>The work will follow the following steps:</p>
<p>Bibliographic study, state of the art of cancer modeling and its pharmacokinetic/pharmacodynamic treatment.&nbsp;</p>
<p>Construction of a mathematical model in the four scenarios: untreated tumor-bearing mice, tumor-bearing mice treated with anti-TIM3 alone, tumor-bearing mice treated with LIP-UMBO alone, and tumor-bearing mice treated with LIP-UMBO and anti-TIM3. &nbsp;</p>
<p>Model parameter estimation and sensitivity analysis.</p>
<p>Mathematical and numerical analysis of the models.</p>
<p>References</p>
<ul>
<li><strong>Idbaih A </strong>et al.<strong>&nbsp;</strong>Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening Increases Anti-Programmed Death-Ligand 1 Delivery and Efficacy in Gl261 Mouse Model. Pharmaceutics. 2023 Jan 30;15(2):455.</li>
<li><strong>Verreault M</strong>, <strong>Idbaih A&nbsp;</strong>et al. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma. J Neurooncol. 2019 Aug;144(1):33-41.</li>
<li><strong>Idbaih A</strong>, et al. Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial. Neuro Oncol. 2023 Jan 5;25(1):123-134.</li>
<li><strong>Idbaih A</strong>, et al. Safety and Feasibility of Repeated and Transient Blood-Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma. Clin Cancer Res. 2019 Jul 1;25(13):3793-3801.</li>
<li><strong>Idbaih A </strong>et al.&nbsp;Clinical trial of blood-brain barrier disruption by pulsed ultrasound. Sci Transl Med. 2016 Jun 15;8(343):343re2.</li>
<li><strong>Idbaih A</strong>, et al. Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter. Neuro Oncol. 2022 Nov 2;24(11):1935-1949.</li>
<li>Da Silva G, Da Silva ICR,&nbsp;<strong>Adimy M</strong>, Mancera PFA. A Mathematical Model for Treatment of Papillary Thyroid Cancer Using the Allee Effect. Journal of Biological Systems. 28(3), 701-718 (2020)</li>
<li>Da Silva G, Da Silva ICR,&nbsp;<strong>Adimy M</strong>, Mancera PFA.&nbsp;The effect of lenvatinib and pembrolizumab on thyroid cancer refractory to iodine 131I simulated by mathematical modeling. Journal of Biological Systems, 30 (01), 93-112 (2022).</li>
<li><strong>Ballesta A</strong>, Zhou Q, Zhang X, Lv H, Gallo JM. Multiscale Design of Cell-Type-Specific Pharmacokinetic/Pharmacodynamic Models for Personalized Medicine: Application to Temozolomide in Brain Tumors. CPT: Pharmacometrics &amp; Systems Pharmacology (2014), 3 e112.</li>
</ul>
    	</div>
    </div>
        
        <div class="grand-item-offre">
		<h4 class="list-group-item-heading">Skills</h4>
		<div class="list-group-item-text text-justify">
			<div class="page" title="Page 2">
<div class="section">
<div class="layoutArea">
<div class="column">
<ul>
<li>have a degree in mathematics</li>
<li>be familiar with PDEs, ODEs, dynamical systems</li>
<li>be familiar with numerical simulation techniques</li>
<li>be familiar with mathematical modeling applied to biology</li>
</ul>
</div>
</div>
</div>
</div>
		</div>
	</div>
	    
        <div class="grand-item-offre">
    	<h4 class="list-group-item-heading">Benefits package</h4>
    	<div class="list-group-item-text text-justify">
    		<ul>
<li>
<ul>
<li>Subsidized&nbsp;meals</li>
<li>Partial reimbursement of public transport costs</li>
<li>Leave: 7 weeks of annual leave + 10 extra days off due to RTT (statutory reduction in working hours) + possibility of exceptional leave (sick children, moving home, etc.)</li>
<li>Possibility of teleworking (90 days / year) and flexible organization of working hours</li>
<li>Social, cultural and sports events and activities</li>
<li>Access to vocational training</li>
<li>Social security coverage under conditions</li>
</ul>
</li>
</ul>
    	</div>
    </div>
        
        <div class="grand-item-offre">
    	<h4 class="list-group-item-heading">Remuneration</h4>
    	<div class="list-group-item-text text-justify">
    		<p><strong>1st and 2nd year:</strong> 2051 euros gross salary /month<br />&nbsp;<br />&nbsp;<strong>3rd year:</strong> 2158 euros gross salary / month</p>
    	</div>
    </div>
      
                    </div>
                </div>
        
                          <div id="right" class="col-sm-5 bloc-right">	
               
                	<div class="row">
                		<div class="col-sm-12" style="padding:15px;margin-bottom :10px;">
                     	                        	                           		<a href="2023-06029.html#" class="btn btn-lg btn-danger btn-postuler-footer" style="width:100%" data-toggle="modal" data-target="#registerOffre">Apply</a>
                        	                    			
            			</div>
            		</div>
        		    	<h4 >Share</h4>

		<ul class="social">
		<li><a target="_blank" href="https://www.facebook.com/sharer.php?u=http://jobs.inria.fr/public/classic/fr/offres/2023-06029&title=Offre+d%27emploi+Inria&description=PhD Position F/M [Campagne DOC MI-NF-LYS-2023] Evaluation of Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening in combination with anti-TIM3 therapeutic antibodies in preclinical mathematical model of Glioblastomas" class="a-facebook btn btn-sm btn-danger"> <i class="fa fa-facebook"></i> </a></li>
		<li><a target="_blank" href="https://www.linkedin.com/shareArticle?mini=true&url=http://jobs.inria.fr/public/classic/fr/offres/2023-06029&title=Offre d'emploi Inria&summary=PhD Position F/M [Campagne DOC MI-NF-LYS-2023] Evaluation of Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening in combination with anti-TIM3 therapeutic antibodies in preclinical mathematical model of Glioblastomas" class="a-linkedin btn btn-sm btn-danger"> <i class="fa fa-linkedin"></i> </a></li>
		<li><a target="_blank" href="http://twitter.com/share?hashtags=Jobs.inria.fr,Emploi,Villeurbanne&text=Offre d'emploi Inria : PhD Position F/M [Campagne DOC MI-NF-LYS-2023] Evaluation of Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening in combination with anti-TIM3 therapeutic antibodies in preclinical mathematical model of Glioblastomas%0A&url=http://jobs.inria.fr/public/classic/fr/offres/2023-06029" class="a-twitter btn btn-sm btn-danger"> <i class="fa fa-twitter"></i> </a></li>
		<li><a target="_blank" href="mailto:?body=Offre d'emploi Inria :%0A PhD Position F/M [Campagne DOC MI-NF-LYS-2023] Evaluation of Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening in combination with anti-TIM3 therapeutic antibodies in preclinical mathematical model of Glioblastomas%0A%0A http://jobs.inria.fr/public/classic/fr/offres/2023-06029&subject=Offre d'emploi Inria: PhD Position F/M [Campagne DOC MI-NF-LYS-2023] Evaluation of Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening in combination with anti-TIM3 therapeutic antibodies in preclinical mathematical model of Glioblastomas" class="a-envelope btn btn-sm btn-danger"> <i class="fa fa-envelope"></i> </a></li>
	</ul>
	
        				
	<h4 >General Information</h4>
	<ul class="nomargin">
									<li><strong>Theme/Domain :</strong>
											Modeling and Control for Life Sciences
						<br/>										
											Biologie et santÃ©, Sciences de la vie et de la terre
													(BAP A)
																
				</li>
							
				<li><strong>Town/city :</strong>
			Villeurbanne
		</li>
				
				<li><strong>Inria Center :</strong>
							<a class="a-inria" target="_blank" href="http://www.inria.fr/centre/lyon">Centre Inria de Lyon</a>
					</li>  
						
					<li><strong>Starting date :</strong>
				2023-10-01
			</li>
							<li><strong>Duration of contract :</strong>
					3 years
				</li>
							
				<li><strong>Deadline to apply :</strong>
			2023-04-14				
		</li>
			</ul>
	
        				
	<h4 >Contacts</h4>
	<ul class="nomargin">
				<li><strong>Inria Team :</strong>
							<a class="a-inria" href="https://www.inria.fr/equipes/DRACULA" target="_blank">DRACULA</a>    	
								</li>
																			<li>
			<strong>PhD Supervisor :</strong>
			<br/>
			Adimy Mostafa
			/
			<a class="a-inria" href="mailto:mostafa.adimy@inria.fr">mostafa.adimy@inria.fr</a>
		</li>
	    	</ul>

        				
	
        			<div class="grand-item-offre">
    					<h4 class="list-group-item-heading">About Inria</h4>
    					<p class="list-group-item-text text-justify">
    		            Inria is the French national research institute dedicated to digital science and technology. It employs 2,600 people. Its 200 agile project teams, generally run jointly with academic partners, include more than 3,500 scientists and engineers working to meet the challenges of digital technology, often at the interface with other disciplines. The Institute also employs numerous talents in over forty different professions. 900 research support staff contribute to the preparation and development of scientific and entrepreneurial projects that have a worldwide impact.
    					</p>
    				</div>
            			
	<h4 >Instruction to apply</h4>
	<div class="text-justify">
		<p>CV, cover letter and Master's grades are expected. One or two letters of recommendation from a professor or master's supervisor will be appreciated.</p>
	</div>
				
	<p class="text-justify">
		<strong>Defence Security : </strong>
		<br/>
		This position is likely to be situated in a restricted area (ZRR), as defined in Decree No. 2011-1425 relating to the protection of national scientific and technical potential (PPST).Authorisation to enter an area is granted by the director of the unit, following a favourable Ministerial decision, as defined in the decree of 3 July 2012 relating to the PPST. An unfavourable Ministerial decision in respect of a position situated in a ZRR would result in the cancellation of the appointment.
    </p>
             	
    <p class="text-justify">
    	<strong> Recruitment Policy :</strong>
        <br/>
		As part of its diversity policy, all Inria positions are accessible to people with disabilities.
    </p>
        <p class="text-justify alert alert-warning">
		<b>Warning</b> : you must enter your e-mail address in order to save your application to Inria. Applications must be submitted online on the Inria website. Processing of applications sent from other channels is not guaranteed.
    </p>
    
             </div>
        </div>
    </div>
</div>

<!-- Modal Creer son compte -->
<div class="modal fade" id="registerOffre" tabindex="-1" role="dialog" aria-labelledby="myModalLabel">
    <div class="modal-dialog" role="document">
        <div class="modal-content ">
            
            <div class="modal-body">
              	<div class="row">
                  	<div class="col-md-6 pull-right">
                  		<button type="button" class="close" data-dismiss="modal" aria-label="Close"><i class="fa fa-remove"></i></button>
                  	</div>
            	</div>
            	<div class="row">
					<div class="col-md-6">
						<div class="form-group">
                        <p class="h4-inria list-group-item-text text-center">
                        I create my account
                        </p> 
                        <p class="h4 list-group-item-text text-center "> 
             			<i class="fa fa-info-circle"></i>
             			 To follow your application online 
                        </p>
            			<p class="h3 list-group-item-text text-center">
                           	<a href="https://jobs.inria.fr/public/en/register?ref=2023-06029"  class=" btn btn-danger">
	        	        		<i class="fa fa-plus"></i> Register
           					</a>
        				</p>
             			
                        </div>
       				</div>
           
           			<div class="col-md-6"  style="border-left: 1px solid #CCC;">
           				<div class="form-group">
           			
                        <p class="h4-inria list-group-item-text text-center">
							I already have an account!
                        </p> 
            			<p class="h3 list-group-item-text text-center">
                           	<a href="https://jobs.inria.fr/public/classic/en/offres/2023-06029/postuler"  class=" btn btn-danger">
	        	        		<i class="fa fa-sign-in"></i> Sign in
           					</a>
        				</p>
        				</div>
       				</div>
            	</div>
        	</div>
            <div class="modal-footer" style="border: none;">
                <button type="button" class="btn btn-default" data-dismiss="modal">Cancel </button>
            </div>
            
        </div>
    </div>
</div>

<script type="text/javascript" src="../../../../library/bootstrap-select-1.12.2/dist/js/bootstrap-select.min.js"></script>
        <script type="text/javascript" src="../../../../js/moment.js"></script>
		<script type="text/javascript" src="../../../../js/bootstrap-datetimepicker.js"></script>
		<script src="../../../../js/cookiechoices.js"></script>
		<script>
				var textCookie = "By continuing to browse this website, you consent to the use of cookies to offer you content and services in line with your interests.";
		var textBtnCookie = "See more";
		var textAccept = "I accept";
				document.addEventListener('DOMContentLoaded', function(event){cookieChoices.showCookieConsentBar(
				textCookie, textAccept, textBtnCookie, '/public/en/mentions-legales');
		});
		</script>

		<script type="text/javascript">

		 ScrollToTop = function() {
             var screen = $(window).scrollTop();
             if (screen > 100) {
               $('.scrollup').fadeIn();
             } else {
               $('.scrollup').fadeOut();
             }
         }
		 $('.scrollup').on('mouseover', function(){
             $(this).addClass('scrollup-mouseover');
             $(this).removeClass('scrollup-mouseout');
            });
         $('.scrollup').on('mouseout', function(){
             $(this).addClass('scrollup-mouseout');
             $(this).removeClass('scrollup-mouseover');
            });

         $('.scrollup').on('click',function () {
             $("html, body").animate({ scrollTop: 0 }, 500);

             return false;
         });

         StopAnimation = function() {
            $("html, body").bind("scroll mousedown DOMMouseScroll mousewheel keyup", function(){
                $('html, body').stop();
            });
         }

         $(window).scroll(function() {
             ScrollToTop();
             StopAnimation();
         });

		</script>


        <!-- Piwik -->
                <script type="text/javascript">
          var _paq = _paq || [];
          /* tracker methods like "setCustomDimension" should be called before "trackPageView" */
          _paq.push(['trackPageView']);
          _paq.push(['enableLinkTracking']);
          (function() {
            var u="//piwik.inria.fr/";
            _paq.push(['setTrackerUrl', u+'piwik.php']);
            _paq.push(['setSiteId', '74']);
            var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
            g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'piwik.js'; s.parentNode.insertBefore(g,s);
          })();
        </script>
                <!-- End Piwik Code -->
    <script type="text/javascript">
    $(document).ready( function(){
        $("postulerOffre").on('click', function(){
            $('#postulerOffre').modal();
        });
    });
    </script>
    
</div>

<footer class="footer">
    <div class="col-md-12 text-center">
            <span class="text-center text-links-footer">
            <a href="../../../en/contact.html"  target="_blank">Contact</a>&nbsp;&nbsp;|&nbsp;
            <a href="../../../en/mentions-legales.html" target="_blank">Legal notice</a>
                        </span>
    </div>
</footer>
<script src="https://commons.inria.fr/bootstrap/ie10-fixup/ie10-viewport-bug-workaround.js"></script><script type="text/javascript" src="../../../../library/bootstrap-select-1.12.2/dist/js/bootstrap-select.min.js"></script>
        <script type="text/javascript" src="../../../../js/moment.js"></script>
		<script type="text/javascript" src="../../../../js/bootstrap-datetimepicker.js"></script>
		<script src="../../../../js/cookiechoices.js"></script>
		<script>
				var textCookie = "By continuing to browse this website, you consent to the use of cookies to offer you content and services in line with your interests.";
		var textBtnCookie = "See more";
		var textAccept = "I accept";
				document.addEventListener('DOMContentLoaded', function(event){cookieChoices.showCookieConsentBar(
				textCookie, textAccept, textBtnCookie, '/public/en/mentions-legales');
		});
		</script>

		<script type="text/javascript">

		 ScrollToTop = function() {
             var screen = $(window).scrollTop();
             if (screen > 100) {
               $('.scrollup').fadeIn();
             } else {
               $('.scrollup').fadeOut();
             }
         }
		 $('.scrollup').on('mouseover', function(){
             $(this).addClass('scrollup-mouseover');
             $(this).removeClass('scrollup-mouseout');
            });
         $('.scrollup').on('mouseout', function(){
             $(this).addClass('scrollup-mouseout');
             $(this).removeClass('scrollup-mouseover');
            });

         $('.scrollup').on('click',function () {
             $("html, body").animate({ scrollTop: 0 }, 500);

             return false;
         });

         StopAnimation = function() {
            $("html, body").bind("scroll mousedown DOMMouseScroll mousewheel keyup", function(){
                $('html, body').stop();
            });
         }

         $(window).scroll(function() {
             ScrollToTop();
             StopAnimation();
         });

		</script>


        <!-- Piwik -->
                <script type="text/javascript">
          var _paq = _paq || [];
          /* tracker methods like "setCustomDimension" should be called before "trackPageView" */
          _paq.push(['trackPageView']);
          _paq.push(['enableLinkTracking']);
          (function() {
            var u="//piwik.inria.fr/";
            _paq.push(['setTrackerUrl', u+'piwik.php']);
            _paq.push(['setSiteId', '74']);
            var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
            g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'piwik.js'; s.parentNode.insertBefore(g,s);
          })();
        </script>
                <!-- End Piwik Code -->
    <script type="text/javascript">
    $(document).ready( function(){
        $("postulerOffre").on('click', function(){
            $('#postulerOffre').modal();
        });
    });
    </script>
</body>
</html>
